Nucleic acid aptamers for neurodegenerative diseases

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Neurodegenerative diseases, including Alzheimer's, Parkinson's, and prion diseases, are increasing globally.
• These conditions are marked by neuronal death and often involve the aggregation of misfolded proteins like amyloid-ß, tau, and α-synuclein.
• The exact mechanisms driving neuronal dysfunction and death in these diseases are not fully understood.

Purpose of the Study:

• To review the potential of nucleic acid aptamers in understanding neurodegenerative diseases.
• To highlight applications of aptamers in diagnosis and therapy for these pathologies.

Main Methods:

• Literature review of nucleic acid aptamers and their roles in neurodegenerative disease research.
• Analysis of aptamer interactions with misfolded proteins associated with various neurodegenerative conditions.

Main Results:

• Nucleic acid aptamers are presented as a novel class of ligands with significant potential.
• Aptamers show promise for developing improved diagnostic tools and therapeutic strategies for neurodegenerative diseases.

Conclusions:

• Nucleic acid aptamers represent a promising avenue for advancing the study and treatment of neurodegenerative diseases.
• Further research into aptamer applications could lead to breakthroughs in managing these challenging conditions.